Your browser doesn't support javascript.
loading
Actinomycetoma in a patient with pre-existing sensorineural hearing loss: a linezolid-based treatment paradigm.
Deo, Kirti; Garg, Priya; Masare, Anuja; Deokar, Shubham Vijay.
Afiliação
  • Deo K; Dermatology, Dr D Y Patil Vidyapeeth, Pune, Maharashtra, India.
  • Garg P; Dermatology, Dr D Y Patil Vidyapeeth, Pune, Maharashtra, India priyagarg8889@gmail.com.
  • Masare A; Dermatology, Dr D Y Patil Vidyapeeth, Pune, Maharashtra, India.
  • Deokar SV; Dermatology, Dr D Y Patil Vidyapeeth, Pune, Maharashtra, India.
BMJ Case Rep ; 17(4)2024 Apr 24.
Article em En | MEDLINE | ID: mdl-38663898
ABSTRACT
Mycetoma is a chronic granulomatous infectious disease with a triad of subcutaneous swelling, discharging sinuses and the presence of granules. The infection may occur following minor trauma or penetrating thorn injury. We report a case of a man in his 40s with a history of thorn prick 9 years ago, followed by the formation of painless discharging sinuses on the right foot for the past 2 years. Clinical, local epidemiological, histopathological examination and Gram stain confirmed the diagnosis of actinomycetoma. Prior to initiating the Welsh regimen, a pretreatment assessment of the patient's auditory function was conducted through pure tone audiometry, indicating the existence of pre-existing high-frequency bilateral sensorineural hearing loss. The patient was treated with linezolid as an alternative to amikacin, at a dosage of 600 mg two times per day, leading to complete resolution within 3 weeks. This underscores linezolid's efficacy as a safe and cost-effective alternative for actinomycetoma, without causing ototoxic side effects.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linezolida / Perda Auditiva Neurossensorial / Micetoma Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linezolida / Perda Auditiva Neurossensorial / Micetoma Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article